NO20054160L - Imidazopyridin-inneholdende kombinasjoner og deres anvendelse i behandling av gastrointestinale inflammatoriske lidelser - Google Patents

Imidazopyridin-inneholdende kombinasjoner og deres anvendelse i behandling av gastrointestinale inflammatoriske lidelser

Info

Publication number
NO20054160L
NO20054160L NO20054160A NO20054160A NO20054160L NO 20054160 L NO20054160 L NO 20054160L NO 20054160 A NO20054160 A NO 20054160A NO 20054160 A NO20054160 A NO 20054160A NO 20054160 L NO20054160 L NO 20054160L
Authority
NO
Norway
Prior art keywords
treatment
imidazopyridine
inflammatory disorders
gastrointestinal inflammatory
containing combinations
Prior art date
Application number
NO20054160A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054160D0 (no
Inventor
Jorg Senn-Bilfinger
Stefan Postius
Wolfgang-Alexander Simon
Wolfgang Kromer
Wilm Buhr
Peter Jan Zimmermann
M Vittoria Chiesa
Andreas Palmer
Christof Brehm
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of NO20054160D0 publication Critical patent/NO20054160D0/no
Publication of NO20054160L publication Critical patent/NO20054160L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20054160A 2003-02-17 2005-09-07 Imidazopyridin-inneholdende kombinasjoner og deres anvendelse i behandling av gastrointestinale inflammatoriske lidelser NO20054160L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003530 2003-02-17
PCT/EP2004/050138 WO2004071391A2 (fr) 2003-02-17 2004-02-16 Nouvelles combinaisons et nouvelle utilisation de composes selectionnes actifs sur le plan pharmaceutique

Publications (2)

Publication Number Publication Date
NO20054160D0 NO20054160D0 (no) 2005-09-07
NO20054160L true NO20054160L (no) 2005-11-14

Family

ID=32864938

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054160A NO20054160L (no) 2003-02-17 2005-09-07 Imidazopyridin-inneholdende kombinasjoner og deres anvendelse i behandling av gastrointestinale inflammatoriske lidelser

Country Status (18)

Country Link
US (1) US20060154954A1 (fr)
EP (1) EP1599175A2 (fr)
JP (1) JP2006517952A (fr)
KR (1) KR20050100671A (fr)
CN (1) CN1747731A (fr)
AR (1) AR044497A1 (fr)
AU (1) AU2004212337A1 (fr)
BR (1) BRPI0407541A (fr)
CA (1) CA2515676A1 (fr)
HR (1) HRP20050790A2 (fr)
IS (1) IS8014A (fr)
MX (1) MXPA05008490A (fr)
NO (1) NO20054160L (fr)
PL (1) PL377581A1 (fr)
RS (1) RS20050603A (fr)
TW (1) TW200418467A (fr)
WO (1) WO2004071391A2 (fr)
ZA (1) ZA200505451B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006117315A1 (fr) * 2005-04-29 2006-11-09 Nycomed Gmbh Composes de promedicaments mutuels utilises comme agents anti-inflammatoires a activite gastro-intestinale protectrice
WO2006117316A1 (fr) * 2005-04-29 2006-11-09 Nycomed Gmbh Composes de promedicaments mutuels utilises comme agents anti-inflammatoires a activite gastro-intestinale protectrice
EP2080513A1 (fr) * 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tétrahydropyridoéthers pour le traitement de la DMA

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
PL193616B1 (pl) * 1998-09-23 2007-02-28 Altana Pharma Ag Tetrahydropirydoetery
EP1127059B1 (fr) * 1998-11-03 2008-02-20 Nycomed GmbH Imidazonaphtyridines
SI1173439T1 (en) * 1999-04-17 2003-10-31 Altana Pharma Ag Haloalkoxy imidazonaphthyridines
MXPA02009550A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Derivados de pirano (2,3,c)imidazo(1,2-a]piridina para el tratamiento de trastornos gastrointestinales.
BR0109483A (pt) * 2000-03-29 2003-06-10 Altana Pharma Ag Pró-drogas de derivados de imidazopiridina
AU783764B2 (en) * 2000-03-29 2005-12-01 Altana Pharma Ag Alkylated imidazopyridine derivatives
ATE356131T1 (de) * 2000-03-29 2007-03-15 Altana Pharma Ag Tricyclische imidazopyridine
CA2426616A1 (fr) * 2000-10-25 2002-05-02 Altana Pharma Ag Imidazopyridines polysubstituees utilisees comme inhibiteurs des secretions gastriques
IL157461A0 (en) * 2001-03-08 2004-03-28 Astrazeneca Ab Astrazeneca Ab Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines

Also Published As

Publication number Publication date
RS20050603A (en) 2007-09-21
PL377581A1 (pl) 2006-02-06
MXPA05008490A (es) 2005-10-18
AU2004212337A1 (en) 2004-08-26
BRPI0407541A (pt) 2006-02-14
NO20054160D0 (no) 2005-09-07
ZA200505451B (en) 2006-08-30
KR20050100671A (ko) 2005-10-19
CN1747731A (zh) 2006-03-15
TW200418467A (en) 2004-10-01
US20060154954A1 (en) 2006-07-13
WO2004071391A2 (fr) 2004-08-26
HRP20050790A2 (en) 2006-12-31
IS8014A (is) 2005-09-08
AR044497A1 (es) 2005-09-14
JP2006517952A (ja) 2006-08-03
EP1599175A2 (fr) 2005-11-30
WO2004071391A3 (fr) 2005-05-12
CA2515676A1 (fr) 2004-08-26

Similar Documents

Publication Publication Date Title
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
NO20053792L (no) Heterocykly-3-sulfonylindazoler som 5-hydroksytryptamin-6 ligander
ATE457313T1 (de) Bicyclische heterocyclische p-38-kinase- inhibitoren
NO20060230L (no) Nye aminobenzofenonforbindelser
BRPI0411825B8 (pt) inibidores de p38 quinase a base de heterociclo de 5 elementos, seus processos de preparação e seus usos, bem como composição farmacêutica
WO2005000298A3 (fr) Inhibiteurs de p-38
NO20056032L (no) Nye pyridopyraziner og anvendelse derav som kinasemodulatorer
TR200400702T4 (tr) AMP özgü fosfodiesteraz inhibtörleri olarak 3-tiazol-4-il-pirolidin türevleri.
CY1108808T1 (el) Ενωσεις μοτιλιδης
WO2006021379A8 (fr) Derives de dihydropteridinone, procedes pour les produire et utilisation de ceux-ci comme medicaments
ATE541843T1 (de) 2-acylamino-4-phenylthiazolderivate, ihre herstellung und anwendung als chemokin antagonisten
ECSP055844A (es) Nuevos compuestos triciclicos
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
HK1080467A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
TW200700064A (en) Novel compounds
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
ATE512968T1 (de) 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6- carboxamid und 2,3,4,5-tetrahydropyrrolo(1,2-a)- diazepin-7-carboxamid- derivate, ihre herstellung und therapeutische verwendung
ATE482211T1 (de) Imidazoä1,2-aüpyridin-anxiolytika
DE60127131D1 (de) Tricyclische imidazopyridine
NO20054160L (no) Imidazopyridin-inneholdende kombinasjoner og deres anvendelse i behandling av gastrointestinale inflammatoriske lidelser
TW200609226A (en) New isobenzoxazinones and their use as ultraviolet light absorbers
MY136822A (en) Derivatives of [6, 7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins
ATE381568T1 (de) Pyrano(2,3-c)imidazo(1,2-a)pyridin-derivate zur behandlung von gastrointestinalen erkrankungen
ATE496047T1 (de) Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien
BRPI0514737A (pt) composições de tocoferol e usos

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application